Search

everythinglearnresearchcommunity

for

Search:↓

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Female pattern hair loss is different from male pattern hair loss and has unclear genetic causes.

PRP shows promise for treating female hair loss but needs more research.

Adipose-derived stem cells help heal burns but need more research.

Hair loss may indicate a higher risk of heart disease and other health issues related to metabolism.

PRP is effective for treating hair loss, improving hair density, count, and thickness.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.

Patients with Type 1 diabetes should be screened for pernicious anemia.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

PRP is promising for skin, hair, and wound treatments but needs standardized methods and more research.

The 11th AICPE Congress in Rimini was a major event in European aesthetic plastic surgery.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.